ImmuPharma "looking forward" to upcoming FDA meetings
News release
by
ImmuPharma PLC
London, UK
|
April 28, 2023 03:00 AM Eastern Daylight Time
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) chief executive Tim McCarthy spoke to Thomas Warner at Proactive's London studio, following what he calls a "very busy time" for the specialty biopharmaceutical company. He discusses the latest developments and next steps for the P140 platform, highlighting the importance of two upcoming meetings with the US FDA.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
